Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-459-7 | CAS number: 107-07-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
For the genetic toxicity in vitro the following studies were identified, briefly summarised below:
Flag |
Author |
Year |
Test |
R |
Conclusion |
Key |
JETOC |
1996 |
Ames |
2 |
Weak positive results only at a dose level of 5 mg/plate (limit concentration) which are not reproducible in independent experiments. |
Key |
Haworth |
1983 |
Ames |
2 |
Weak positive at high concentrations near or above the limit dose recommended in OECD Guideline 471. |
Sup |
Nakamura |
1979 |
Ames |
2 |
In the Ames test only at extremely high dose levels an increase in the number of revertants was found in TA1535 with metabolic activation. |
Sup |
Elmore |
1976 |
Ames |
4 |
At dose levels up to 80 µg/ml no mutagenic effects were found without metabolic activation in S. typhimurium TA1535, TA100, TA1537, TA1538, and TA98. |
Sup |
Bartsch |
1975 |
Ames |
2 |
Increase in revertants only at high dose levels > 5 mg/plate in S. typhimurium TA1530. |
Sup |
Bignami |
1980 |
Ames |
2 |
Positive results in S. typhimurium TA1535 at extremely high concentrations. |
Sup |
Malaveille |
1975 |
Ames |
2 |
Mutagenic effects in S. typhimurium TA1530 at a dose level of 3.2 mg/ml with and without metabolic activation. |
Sup |
McCann |
1975 |
Ames |
2 |
In the Ames test no mutagenic activity was found in TA100 and TA1535 at concentrations up to 5 mg/plate with and without metabolic activation. |
Sup |
Stolzenberg |
1980 |
Ames |
2 |
In the Ames test only weak mutagenic activity was found in TA100 at a concentrations of 8 mg/plate with and without metabolic activation. |
Sup |
Min |
1987 |
Ames |
2 |
In the Ames test in S. typhimurium TA98 and TA100 weak positive effects were found with and without metabolic activation at extremely high dose levels. |
Sup |
Rosenkranz |
74a/77 |
Ames |
2 |
In the Ames test in S. typhimurium TA1530 weak mutagenic effects were found without metabolic activation at high dose levels. |
Sup |
Rosenkranz |
74b/77 |
Ames |
2 |
In the Ames test in S. typhimurium TA1530 & 1535 mutagenic effects were found without metabolic activation at high dose levels > the recommended max. concentration of 5 mg/plate. |
Sup |
Rannug |
1976 |
Ames |
2 |
No mutagenic effects in S. typhimurium TA1535 without metabolic activation even at extremely high doses (80 mg/ml). |
Sup |
Norpoth |
1980 |
Ames |
4 |
Using one dose level negative results were obtained in the Ames test with S. typhimurium TA98 and E. coli WP2uvrA. |
Sup |
Pfeiffer |
1980 |
Ames |
3 |
In the Ames test positive results were obtained in S. typhimurium TA100 & TA1535 but no final evaluation is possible without data on concurrent controls. |
Sup |
Loefroth |
1978 |
Ames |
2 |
In the Ames test a weak positive result was found in S. typhimurium TA100 with metabolic activation at extremely high dose levels. |
Sup |
Kharchenikova |
1997 |
Ames |
4 |
In the Ames test mutagenic effects were recorded in S. typhimurium TA100 with and without metabolic activation only at extremely high dose levels. |
Sup |
Laumbach |
1977 |
Ames |
4 |
No mutagenic effects in the Ames test without metabolic activation using the S. typhimurium strains TA98, TA100, TA1535, TA1537, TA1538. |
Sup |
Voogd |
1972 |
Bac gen |
2 |
Induction of gene mutation in bacteria without metabolic activation at high concentrations in the Fluctuation test. |
Sup |
Bignami |
1980 |
Bac gen |
2 |
In Streptomyces coelicolor no reverse mutation was noted even at very high dose levels. |
Sup |
Knaap |
1982 |
Bac gen |
2 |
Dose dependent mutagenic effects in Klebsiella pneumoniae using a forward mutation assay. |
Sup |
Elmore |
1976 |
Bac DNA |
2 |
In a modified rec-assay no DNA damage was detected in Bacillus subtilis. |
Sup |
Laumbach |
1977 |
Bac DNA |
2 |
No DNA damage was detected in the modified rec-assay. |
Sup |
Rosenkranz |
74/77 |
Bac DNA |
2 |
DNA repair deficient E. coli revealed an increased inhibition compared to the proficient strain indicating DNA damage. |
Sup |
DeMartini |
1992 |
Bac DNA |
2 |
Positive results in the Microscreen prophage-induction assay in E. coli without metabolic activation and weak positive results with metabolic activation. |
Key |
Loprieno |
1977 |
Mitotic recom |
2 |
In a study on mitotic recombination in Saccharomyces cerevisiae D4 negative results were obtained with and without metabolic activation at cytotoxic dose levels. |
Sup |
Crebelli |
1984 |
Mitotic recom |
2 |
In Aspergillus nidulans somatic segregation was induced without metabolic activation at a high dose level of 6 mg/ml. |
Key |
Loprieno |
1977 |
Gene mutat yeast |
2 |
In a study on forward mutation in Schizosaccharomyces pombe P1 negative results were obtained with and without metabolic activation at cytotoxic dose levels. |
Sup |
Bignami |
1980 |
Gene mutat yeast |
2 |
Ambiguous test results in forward gene mutatation assays in Aspergillus nidulans at very high dose levels. |
Key |
Ivett |
1989 |
Cytogenetic |
2 |
In CHO cells the test substance was mutagenic in the chromosome aberration assay with metabolic activation at cytotoxic concentrations. |
Key |
JETOC |
1996 |
Cytogenetic |
2 |
In CHL cells no increase in chromosome aberration was detected without metabolic activation at dose levels up to 5 mg/ml (limit dose). |
Key |
McGregor |
86/88 |
Mouse |
2 |
In the mouse lymphoma assay 2-chloroethanol induced with metabolic activation a dose dependent reproducible increase in mutations also at concentrations without cytotoxic effects. |
Sup |
Brown |
1979 |
Mouse |
4 |
Mutagenic effects in the mouse lymphoma assay without metabolic activation. |
Sup |
Hubermann |
1975 |
HPRT |
2 |
In the HPRT assay no mutagenic activity was found without metabolic activation at dose levels < 2.5 mM (200 µg/ml). |
Sup |
Knaap |
1982 |
HPRT |
2 |
In the HPRT assay in mouse lymphoma cells no mutagenic effects were detected without metabolic activation even at dose levels above the recommended limit dose. |
Sup |
Stankowski |
1988 |
HPRT |
4 |
No gene mutagenic effects in the HPRT assay in CHO cells with and without metabolic activation. |
Sup |
Flowers |
1988 |
HPRT |
4 |
Gene mutagenic effects in the HPRT assay in CHO cells in the presence of metabolic activation but negative results without metabolic activation. |
Sup |
Stankowski |
1988 |
XPRT |
4 |
Presumably no gene mutagenic effects in the XPRT assay in AS52 cells without metabolic activation and non-reproducible weak positive results with metabolic activation. |
Sup |
Huberman |
1975 |
ATPase |
2 |
In the Na+/K+ ATPase assay no mutagenic activity was found without metabolic activation at dose levels < 2.5 mM (200 µg/ml). |
Key |
Ivett |
1989 |
SCE assay |
2 |
An increased incidence in sister chromatid exchange in CHO cells with and without metabolic activation was reported; higher genotoxic activity was seen with metabolic activation. |
Sup |
Stich |
1981 |
UDS test |
4 |
Induction of unscheduled DNA synthesis in mammalian fibroblast. |
Sup |
Brambilla |
1992 |
UDS test |
4 |
No increases in UDS of exposed hepatocytes were detected at the max. non-cytotoxic concentration. |
Sup |
Allavena |
1992 |
UDS test |
2 |
In the UDS assay no genotoxic activity was found in rat hepatocytes exposed for 20 h to concentrations up to the cytotoxicity threshold. |
Sup |
Allavena |
1992 |
Alkaline elution Assay |
2 |
In the alkaline elution assay no genotoxic activity was found in rat hepatocytes exposed for 20 h to concentrations up to the cytotoxicity threshold. |
Sup |
Painter |
1982 |
DNA synth inhib |
2 |
No inhibition of DNA synthesis (indicating no DNA damage) was detected in HeLa cells after exposure to the test substance with and without metabolic activation. |
Sup |
Matthews |
1993 |
Cell |
2 |
In the cell transformation assay in BALB/c-3T3 cells without metabolic activation positive results were reported even at non-cytotoxic concentrations. |
Sup |
Kajiwara |
1997 |
Cell |
2 |
In the cell transformation assay in BALB/c-3T3 cells tested without metabolic activation negative results were reported even at cytotoxic concentrations and dose levels up to 5 mg/ml. |
R: Reliability
Overall summary:
Ames test: in most assays positive
Bac gen mutat: equivocal
Bac DNA damage: equivocal
Mitotic recom/Gene mutat yeast: Key studies negative
Cytogenetic: equivocal
ATPase assay: negative
SCE assay: positive
UDS test: in most assays negative
Alkaline elution assay: negative
Mouse lymphoma: positive
HPRT/XPRT: in most assays negative
DNA synth inhib: negative
Cell transformation: equivocal
Conclusion:
The available in vitro data demonstrated equivocal results. Thus, it is not possible to conclude finally on the in vitro genotoxic potential of 2 -chloroethanol.
For the genetic toxicity in vivo the following studies were identified and briefly summarised:
Purpose Flag |
Author |
Year |
Test |
R |
Conclusion |
Key |
Shelby |
1993 |
mouse micronucleus |
2 |
In the mouse bone marrow micronucleus assay no mutagenic activity was detected at dose levels reaching toxicity threshold. |
Sup |
Allavena |
1992 |
rat
|
2 |
Male rats gavaged once or twice with 45 mg/kg bw did not show clastogenic effects in the liver or bone marrow. |
Sup |
Conan |
1979 |
mouse micronucleus |
3 |
In the mouse bone marrow micronucleus assay oral doses of up to 120 mg/kg bw did not induce clastogenic effects,however, the study is of limited validity. |
Sup |
Shelby |
1995 |
mouse micronucleus |
4 |
In an insufficiently documented mouse bone marrow micronucleus assay no mutagenic activity was detected at dose levels reaching toxicity threshold. |
Sup |
Shelby |
1995 |
mouse cytogenetic |
4 |
In an insufficiently documented chromosome aberration assay in mice no mutagenic activity was found at dose levels up to the toxicity threshold. |
Sup |
Semenova |
1977 |
rat
|
4 |
Clastogenic effects were reported in a Russian bone marrow cytogenetic study in rats after repeated inhalation or oral exposure, however, the validity of these results is questionable. |
Key |
Epstein |
1972 |
mouse Lethal
|
2 |
In the mouse dominant lethal assay no mutagenic effects were detected at dose levels up to 130 mg/kg bw/day. |
Key |
FDA/Sheu |
1980/1983 |
mouse transl.
|
2 |
In the mouse heritable translocation assay i.p. injection of doses up to 60 mg/kg bw/day for 5 weeks did not induce structural or numerical chromosome aberrations. |
Sup |
Allavena |
1992 |
rat
|
2 |
Isolated hepatocytes of male rats gavaged once or twice with 45 mg/lcg bw did not show genotoxic effects measured by the UDS assay. |
Sup |
Storer |
1985 |
mouse alkaline elution |
2 |
No SingleStrandbreaksandno alkaline labile site were found in hepatic DNA of mice using the alkaline / elution technique 4 h after single i.p. injection of dosesupto 96 mg/kg bw (hepatoxic dose level). |
Sup |
Allavena |
1992 |
rat alkaline elution |
2 |
Isolated hepatocytes of male rats gavaged once or twice with 45 mg/kg bw did not show genotoxic effects measured by the alkaline elution assay. |
Sup |
Kitchin |
1993 |
rat alkaline elution |
2 |
In female rats treated twice via gavage with doses up to 54 mg/kg bw no DNA damage was detected in the alkaline elution assay. |
Key |
Knaap |
1982 |
Drosophila |
2 |
In the SLRL assay in Drosophila no gene mutagenic activity on male germ cells was detected. |
Sup |
NTP, 495716 |
1986-1990 |
SCE |
2 |
In the sister chromatid exchange assay negative results were observed in concentrations of 18.75, 37.5 and 75 mg/kg bw. |
Sup |
Valencia |
1985 |
Drosophila |
2 |
No gene mutation was induced in the Drosophila SLRL test after 4 h inhalation to 400 ppm. |
Non |
Isakova |
1971 |
Cytogengetic |
3 |
Retarded chromosomses in the bone marrow, increase in the number of chromosomal aberrations (Breakage) were observed. The result is however invalid, respectively (creteria making the stuty invalid see above). |
Summary: 14 out of 16 studies demonstrated negative results for the genotoxicity of 2 -chloroethanol. In two cytogenetic studies in rats an increased number of chromosomal abberation was mentioned. The validity of the results of the two cytogenetic studies were however questionable. Conclusion: Based on the available data 2 -chloroethanol does not cause genotoxic effects in vivo. Overall conclusion: The results obtained with 2 -chloroethanol in a variety of in vitro test systems for genotoxicity were inconsistent. In contrast, the available in vivo studies provided no evidence of genotoxic effects for 2 -chloroethanol. Thus, it is concluded that 2 -chloroethanol is not genotoxic.
Short description of key information:
2 -chloroethanol is not genotoxic.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the available data, the test item is not subject to C&L according to Directive 67/548/EEC or the Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.